Avadel Pharmaceuticals plc (AVDL) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 172.23M | 159.1M | 139.26M | 134.21M | 127.26M | 125.78M | 136.03M | 134.2M | 172.25M | 171.23M | 109.47M | 100.84M |
| Cash & Short-Term Investments | 91.58M | 81.55M | 66.48M | 73.78M | 65.81M | 71.38M | 88.79M | 105.11M | 153.18M | 160.51M | 100.92M | 96.5M |
| Cash Only | 79.81M | 63.4M | 56.37M | 51.37M | 28.58M | 28.85M | 35.79M | 31.17M | 51.81M | 49.98M | 83.39M | 73.98M |
| Short-Term Investments | 11.76M | 18.14M | 10.11M | 22.41M | 37.23M | 42.53M | 52.99M | 73.94M | 101.37M | 110.53M | 17.53M | 22.52M |
| Accounts Receivable | 42.44M | 40.63M | 41.58M | 34.1M | 37.1M | 34.3M | 23.98M | 13.43M | 7.51M | 2.82M | 2.35M | 2.32M |
| Days Sales Outstanding | 199.98 | 217.68 | 289.03 | 246.88 | 270.71 | 301.68 | 322.12 | 251.9 | 390.66 | 687.55 | - | - |
| Inventory | 23.91M | 23.48M | 20.41M | 20.3M | 16.1M | 13.31M | 11.93M | 10.38M | 5.29M | 1.44M | 0 | 0 |
| Days Inventory Outstanding | -2.91K | 1.35K | 1.34K | 1.54K | 954.57 | 1.74K | 2.86K | 5.47K | 16.49K | 14.59K | - | - |
| Other Current Assets | 798K | 773K | 825K | 882K | 1.95M | 672K | 3.32M | 913K | 6.28M | 6.46M | 811K | 504K |
| Total Non-Current Assets | 27.22M | 28.05M | 28.69M | 30.03M | 31M | 31.74M | 31.86M | 30.5M | 30.84M | 29.75M | 31.27M | 103.28M |
| Property, Plant & Equipment | 3.01M | 11.01M | 11.66M | 12.86M | 13.76M | 14.51M | 14.47M | 13.08M | 3.45M | 1.95M | 2.26M | 2.55M |
| Fixed Asset Turnover | 25.73x | 6.19x | 4.50x | 3.92x | 3.64x | 2.86x | 1.88x | 1.49x | 2.03x | 0.77x | - | - |
| Goodwill | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 409K | 420K | 1.25M | 1.23M |
| Other Non-Current Assets | 7.38M | 208K | 190K | 337K | 399K | 391K | 553K | 579K | 10.15M | 10.54M | 10.93M | 11.32M |
| Total Assets | 199.45M | 187.16M | 167.95M | 164.24M | 158.25M | 157.52M | 167.9M | 164.7M | 203.1M | 200.98M | 140.74M | 204.13M |
| Asset Turnover | 0.39x | 0.36x | 0.31x | 0.31x | 0.32x | 0.26x | 0.16x | 0.12x | 0.03x | 0.01x | - | - |
| Asset Growth % | 26.03% | 18.81% | 0.03% | -0.28% | -22.08% | -21.62% | 19.3% | -19.32% | 39.34% | 27.25% | -36.35% | -17.45% |
| Total Current Liabilities | 62.49M | 57.06M | 50.93M | 48.83M | 42.78M | 44.61M | 47.81M | 36.85M | 54.05M | 51.5M | 79.36M | 55.79M |
| Accounts Payable | 12.58M | 10.11M | 9.12M | 7.33M | 7.92M | 9.79M | 18.96M | 11.43M | 13.26M | 11.79M | 10.02M | 7.89M |
| Days Payables Outstanding | -1.53K | 579.89 | 596.62 | 555.84 | 469.49 | 1.28K | 4.55K | 6.02K | 41.38K | 119.5K | - | 4.91K |
| Short-Term Debt | 740K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22.1M | 21.63M | 61.39M | 38.63M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 40.33M | 24.47M | 20.3M | 21.01M | 17.57M | 16.72M | 11.28M | 11.8M | 12.62M | 13.68M | 6.37M | 7.66M |
| Current Ratio | 2.76x | 2.79x | 2.73x | 2.75x | 2.97x | 2.82x | 2.85x | 3.64x | 3.19x | 3.32x | 1.38x | 1.81x |
| Quick Ratio | 2.37x | 2.38x | 2.33x | 2.33x | 2.60x | 2.52x | 2.60x | 3.36x | 3.09x | 3.30x | 1.38x | 1.81x |
| Cash Conversion Cycle | -1.18K | 984.26 | 1.03K | 1.23K | 755.79 | 762.38 | -1.36K | -302.71 | -24.49K | -104.22K | - | - |
| Total Non-Current Liabilities | 38.74M | 39.38M | 42.95M | 41.55M | 40.81M | 42.62M | 41.71M | 40.1M | 38.9M | 6.28M | 99.54M | 169.48M |
| Long-Term Debt | 34.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31.15M | 0 | 93.14M | 91.61M |
| Capital Lease Obligations | 1.81M | 2M | 2.19M | 1.12M | 1.22M | 1.31M | 1.45M | 1.69M | 1.93M | 490K | 638K | 780K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71.34M |
| Other Non-Current Liabilities | 2.1M | 37.38M | 40.76M | 40.43M | 39.59M | 41.31M | 40.26M | 38.41M | 5.82M | 5.79M | 5.77M | 5.74M |
| Total Liabilities | 101.22M | 96.45M | 93.88M | 90.39M | 83.59M | 87.23M | 89.52M | 76.96M | 92.95M | 57.78M | 178.91M | 225.27M |
| Total Debt | 37.38M | 2.73M | 2.9M | 1.7M | 1.94M | 2.17M | 2.4M | 2.62M | 55.18M | 22.12M | 155.16M | 131.02M |
| Net Debt | -42.44M | -60.68M | -53.48M | -49.67M | -26.64M | -26.67M | -33.39M | -28.54M | 3.37M | -27.86M | 71.77M | 57.04M |
| Debt / Equity | 0.38x | 0.03x | 0.04x | 0.02x | 0.03x | 0.03x | 0.03x | 0.03x | 0.50x | 0.15x | - | - |
| Debt / EBITDA | 12.25x | 0.27x | - | - | 2.74x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -13.90x | -6.10x | - | - | -37.63x | - | - | - | - | - | - | - |
| Interest Coverage | 0.80x | 3.77x | -1.34x | -1.22x | -0.12x | -4.69x | -10.04x | -10.58x | -17.75x | -21.59x | -8.68x | -7.13x |
| Total Equity | 98.22M | 90.71M | 74.07M | 73.85M | 74.66M | 70.29M | 78.38M | 87.74M | 110.15M | 143.19M | -38.17M | -21.14M |
| Equity Growth % | 31.56% | 29.05% | -5.5% | -15.83% | -32.22% | -50.91% | 305.38% | 514.94% | 985.44% | 4397.48% | -169.1% | -127.02% |
| Book Value per Share | 0.97 | 0.92 | 0.77 | 0.77 | 0.78 | 0.73 | 0.85 | 1.02 | 1.23 | 1.85 | -0.60 | -0.33 |
| Total Shareholders' Equity | 98.22M | 90.71M | 74.07M | 73.85M | 74.66M | 70.29M | 78.38M | 87.74M | 110.15M | 143.19M | -38.17M | -21.14M |
| Common Stock | 972K | 967K | 966K | 965K | 963K | 961K | 960K | 898K | 893K | 893K | 644K | 628K |
| Retained Earnings | -789.56M | -789.58M | -799.25M | -794.33M | -789.28M | -786.66M | -772.84M | -745.5M | -716.71M | -680.44M | -616M | -585.22M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -23.58M | -23.65M | -24.31M | -24.58M | -23.8M | -24.21M | -23.76M | -23.17M | -25.95M | -25.94M | -26.03M | -26.34M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |